scholarly journals Accidental Overdose of "Parstelin."

BMJ ◽  
1962 ◽  
Vol 2 (5321) ◽  
pp. 1755-1756 ◽  
Author(s):  
R. E. Midwinter
Keyword(s):  
2017 ◽  
Vol 25 (6) ◽  
pp. e20-e22 ◽  
Author(s):  
İlknur Çağlar ◽  
Mine Düzgöl ◽  
Ahu Kara ◽  
Süleyman Nuri Bayram ◽  
Hurşit Apa ◽  
...  

1960 ◽  
Vol 106 (445) ◽  
pp. 1455-1458 ◽  
Author(s):  
I. C. Lodge Patch ◽  
M. D. Eilenberg ◽  
E. H. Hare

The use of barbiturates in the treatment of insomnia carries a constant risk of habituation and of fatal poisoning from suicidal or accidental overdose. For these reasons, new non-barbiturate hypnotics deserve the closest attention. Ethinamate (“Valmidate”) and methyprylone (“Noludar”) are two such drugs. No trial comparing the hypnotic efficacy of ethinamate with a barbiturate has yet been reported, though Gruber et al. (1954) found the day-time sedative effect of 500 mg. ethinamate to be less (in duration of action) than 100 mg. of quinalbarbitone sodium. Methyprylone has been compared with barbiturate by Stewart (1956) who found 200 mg. equivalent to 100 mg. of amylo- or butobarbitone, by Lasagna (1956) who found 250 mg. equivalent to 100 mg. of pento- or quinal-barbitone, and by Thomson (1958) who found 400 mg. equivalent to 100 mg. of quinalbarbitone.


Addiction ◽  
1999 ◽  
Vol 94 (8) ◽  
pp. 1179-1189 ◽  
Author(s):  
Gerald A. Bennett ◽  
David S. Higgins

Author(s):  
Heidi N. Eukel ◽  
Elizabeth Skoy ◽  
Amy Werremeyer ◽  
Siri Burck ◽  
Mark Strand

Seizure ◽  
2005 ◽  
Vol 14 (3) ◽  
pp. 151-156 ◽  
Author(s):  
S. Sukumaran ◽  
J. Herbert ◽  
J. Tracey ◽  
N. Delanty

2011 ◽  
Vol 2011 ◽  
pp. 1-14 ◽  
Author(s):  
Sarah J. Mitchell ◽  
Alice E. Kane ◽  
Sarah N. Hilmer

Optimal pharmacotherapy is determined when the pharmacokinetics and pharmacodynamics of the drug are understood. However, the age-related changes in pharmacokinetics and pharmacodynamics, as well as the increased interindividual variation mean optimal dose selection are a challenge for prescribing in older adults. Poor understanding of how hepatic clearance and toxicity are different with age results in suboptimal dose selection, poor efficacy, and/or increased toxicity. Of particular concern is the analgesic paracetamol which has been in use for more than 50 years and is consumed by a large proportion of older adults. Paracetamol is considered to be a relatively safe drug; however, caution must be taken because of its potential for toxicity. Paracetamol-induced liver injury from accidental overdose accounts for up to 55% of cases in older adults. Better understanding of how age affects the hepatic clearance and toxicity of drugs will contribute to evidence-based prescribing for older people, leading to fewer adverse drug reactions without loss of benefit.


2020 ◽  
Vol 60 (1) ◽  
pp. 117-121 ◽  
Author(s):  
Elizabeth Skoy ◽  
Heidi Eukel ◽  
Amy Werremeyer ◽  
Mark Strand ◽  
Oliver Frenzel ◽  
...  

Neurology ◽  
2020 ◽  
Vol 95 (7) ◽  
pp. e921-e929 ◽  
Author(s):  
Sam M. Hermes ◽  
Nick R. Miller ◽  
Carin S. Waslo ◽  
Susan C. Benes ◽  
Emanuel Tanne

ObjectiveTo determine (1) if mortality among patients with idiopathic intracranial hypertension (IIH) enrolled in the Intracranial Hypertension Registry (IHR) is different from that of the general population of the United States and (2) what the leading underlying causes of death are among this cohort.MethodsMortality and underlying causes of death were ascertained from the National Death Index. Indirect standardization using age- and sex-specific nationwide all-cause and cause-specific mortality data extracted from the Centers for Disease Control and Prevention Wonder Online Database allowed for calculation of standardized mortality ratios (SMR).ResultsThere were 47 deaths (96% female) among 1437 IHR participants that met inclusion criteria. The average age at death was 46 years (range, 20–95 years). Participants of the IHR experienced higher all-cause mortality than the general population (SMR, 1.5; 95% confidence interval [CI], 1.2–2.1). Suicide, accidents, and deaths from medical/surgical complications were the most common underlying causes, accounting for 43% of all deaths. When compared to the general population, the risk of suicide was over 6 times greater (SMR, 6.1; 95% CI, 2.9–12.7) and the risk of death from accidental overdose was over 3 times greater (SMR, 3.5; 95% CI, 1.6–7.7). The risk of suicide by overdose was over 15 times greater among the IHR cohort than in the general population (SMR, 15.3; 95% CI, 6.4–36.7).ConclusionsPatients with IIH in the IHR possess significantly increased risks of death from suicide and accidental overdose compared to the general population. Complications of medical/surgical treatments were also major contributors to mortality. Depression and disability were common among decedents. These findings should be interpreted with caution as the IHR database is likely subject to selection bias.


Sign in / Sign up

Export Citation Format

Share Document